MENU
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Protalix BioTherapeutics (PLX) Ownership - Who owns Protalix BioTherapeutics?
Industry: @Servicestothe Health Industry
Profile
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
103.7M
P/E Ratio
13.00
Total Cash
N/A
Projected Growth
N/A
Total Debt
26.37M
Revenue
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price
Fundamentals
PLX
Capitalization
104M
P/E Ratio
13.00
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
26.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
N/A
ROE
N/A
Book Value
29.8M
P/B Ratio
3.63
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73K
Current Ratio
1.38
Current Revenue Per Employee
18019.23
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
30.58
Revenue To Assets
N/A
Shares Held By Institutions
8.83M
Shares Outstanding - Current
73.5M
Total Liabilities
60M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.787
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of recombinant therapeutic proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com